Co-prescription of Strong CYP1A2 Inhibitors and the Risk of...

  • Main
  • 2018 / 09
  • Co-prescription of Strong CYP1A2 Inhibitors and the Risk of...
Clinical Pharmacology & Therapeutics 2018 / 09

Co-prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study

Chaugai, Sandip, Dickson, Alyson L., Shuey, Megan M., Feng, QiPing, Barker, Katherine A., Wei, Wei-Qi, Luther, James M., Stein, C. Michael, Chung, Cecilia P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1002/cpt.1233
Date:
September, 2018
File:
PDF, 1.39 MB
english, 2018
Conversion to is in progress
Conversion to is failed